Published in Stroke on May 03, 2012
CorPath® GRX Neuro Study | NCT04236856
Prevention of Vasospasm in SAH Through CSF Treatment (PREVAIL) | NCT04490161
Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol (2013) 1.54
Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives. Surg Neurol Int (2017) 1.45
Effect of a fever control protocol-based strategy on ventilator-associated pneumonia in severely brain-injured patients. Crit Care (2014) 1.32
Decompressive craniectomy: past, present and future. Nat Rev Neurol (2013) 1.24
The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2013) 1.18
P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiol Dis (2013) 1.17
Roles of hypertension in the rupture of intracranial aneurysms. Stroke (2013) 1.13
The harmful effects of subarachnoid hemorrhage on extracerebral organs. Biomed Res Int (2014) 1.10
Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06
Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol (2013) 1.04
Brain temperature: physiology and pathophysiology after brain injury. Anesthesiol Res Pract (2012) 1.00
Incidence of and factors associated with manipulation of nimodipine dosage in patients with aneurysmal subarachnoid hemorrhage. Can J Hosp Pharm (2014) 0.93
Controversies in the anesthetic management of intraoperative rupture of intracranial aneurysm. Anesthesiol Res Pract (2014) 0.93
Therapeutic hypothermia for neuroprotection: history, mechanisms, risks, and clinical applications. Neurohospitalist (2014) 0.93
Transcranial Doppler ultrasound: a review of the physical principles and major applications in critical care. Int J Vasc Med (2013) 0.93
Aneurysmal Subarachnoid Hemorrhage. J Neurosurg Anesthesiol (2015) 0.89
Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic Interventions. Neurol Res Int (2013) 0.89
Monitoring in Neurointensive Care - The Challenge to Detect Delayed Cerebral Ischemia in High-Grade Aneurysmal SAH. Front Neurol (2014) 0.88
Intracranial extravasation of contrast medium during diagnostic CT angiography in the initial evaluation of subarachnoid hemorrhage: report of 16 cases and review of the literature. Springerplus (2013) 0.88
Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. PLoS One (2012) 0.87
Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. Stroke (2014) 0.87
The expanding realm of endovascular neurosurgery: flow diversion for cerebral aneurysm management. Methodist Debakey Cardiovasc J (2015) 0.86
Parenteral diclofenac infusion significantly decreases brain-tissue oxygen tension in patients with poor-grade aneurysmal subarachnoid hemorrhage. Crit Care (2013) 0.85
Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol (2015) 0.84
Clinical practice guideline for the management of intracranial aneurysms. Neurointervention (2014) 0.83
Human cerebrospinal fluid microRNA: temporal changes following subarachnoid hemorrhage. Physiol Genomics (2016) 0.83
Accuracy and precision of calibrated arterial pulse contour analysis in patients with subarachnoid hemorrhage requiring high-dose vasopressor therapy: a prospective observational clinical trial. Crit Care (2014) 0.83
Systolic Blood Pressure Variability is a Novel Risk Factor for Rebleeding in Acute Subarachnoid Hemorrhage: A Case-Control Study. Medicine (Baltimore) (2016) 0.83
Cost-effectiveness of transfers to centers with neurological intensive care units after intracerebral hemorrhage. Stroke (2014) 0.83
Usefulness of Dexmedetomidine during Intracerebral Aneurysm Coiling. J Korean Neurosurg Soc (2014) 0.83
Changes in Cerebral Perfusion with Induced Hypertension in Aneurysmal Subarachnoid Hemorrhage: A Pilot and Feasibility Study. Neurocrit Care (2017) 0.83
Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand? Neurol Res Int (2013) 0.82
Description of the vasospasm phenomena following perimesencephalic nonaneurysmal subarachnoid hemorrhage. Biomed Res Int (2013) 0.82
Long-term impact of perfusion CT data after subarachnoid hemorrhage. Neuroradiology (2013) 0.82
Multimodality monitoring, inflammation, and neuroregeneration in subarachnoid hemorrhage. Neurosurgery (2014) 0.81
Research studies that have influenced practice of neuroanesthesiology in recent years: A literature review. Indian J Anaesth (2013) 0.81
Levetiracetam use in the critical care setting. Front Neurol (2013) 0.81
Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort study. Crit Care (2015) 0.81
Reduced-dose CT protocol for the assessment of cerebral vasospasm. Neuroradiology (2015) 0.81
Insurance status is associated with treatment allocation and outcomes after subarachnoid hemorrhage. PLoS One (2014) 0.80
The 'Sphere': A Dedicated Bifurcation Aneurysm Flow-Diverter Device. Cardiovasc Eng Technol (2014) 0.80
Subdural hematoma caused by rupture of a posterior cerebral artery aneurysm. Neurosciences (Riyadh) (2016) 0.80
Cerebral vasospasm pharmacological treatment: an update. Neurol Res Int (2013) 0.80
Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial. BMC Neurol (2013) 0.80
Cost-effectiveness of CTA, MRA and DSA in patients with non-traumatic subarachnoid haemorrhage. Insights Imaging (2013) 0.80
Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage. Vasc Health Risk Manag (2013) 0.80
Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol (2014) 0.80
Red blood cell transfusion in patients with traumatic brain injury: a systematic review protocol. Syst Rev (2014) 0.80
High risk for seizures following subarachnoid hemorrhage regardless of referral bias. Neurocrit Care (2014) 0.80
Early and persistent high level of PS 100β is associated with increased poor neurological outcome in patients with SAH: is there a PS 100β threshold for SAH prognosis? Crit Care (2016) 0.80
Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage. PLoS One (2012) 0.79
Cost of Treatment of Cerebral Aneurysm Embolization: Study of Associated Factors. Neurol Ther (2016) 0.79
Subarachnoid hemorrhage induces an early and reversible cardiac injury associated with catecholamine release: one-week follow-up study. Crit Care (2014) 0.79
Encephalic hemodynamic phases in subarachnoid hemorrhage: how to improve the protective effect in patient prognoses. Neural Regen Res (2015) 0.79
Brain iron metabolism and brain injury following subarachnoid hemorrhage: iCeFISH-pilot (CSF iron in SAH). Neurocrit Care (2014) 0.79
Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension. Ann Intensive Care (2016) 0.79
Risk factors and pathogens involved in early ventilator-acquired pneumonia in patients with severe subarachnoid hemorrhage. Eur J Clin Microbiol Infect Dis (2013) 0.78
Evaluation of a metal artifact reduction algorithm applied to post-interventional flat detector CT in comparison to pre-treatment CT in patients with acute subarachnoid haemorrhage. Eur Radiol (2016) 0.78
Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients. Crit Care (2013) 0.78
Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. Sci Rep (2014) 0.78
Effects of tight computerized glucose control on neurological outcome in severely brain injured patients: a multicenter sub-group analysis of the randomized-controlled open-label CGAO-REA study. Crit Care (2014) 0.78
Endovascular and surgical options for ruptured middle cerebral artery aneurysms: review of the literature. Stroke Res Treat (2014) 0.78
Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice. J Cereb Blood Flow Metab (2015) 0.78
Intravenous flat-detector computed tomography angiography for symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. ScientificWorldJournal (2014) 0.78
Cerebral microcirculatory failure after subarachnoid hemorrhage is reversed by hyaluronidase. J Cereb Blood Flow Metab (2015) 0.78
Use of Intra-aortic- Balloon Pump Counterpulsation in Patients with Symptomatic Vasospasm Following Subarachnoid Hemorrhage and Neurogenic Stress Cardiomyopathy. J Vasc Interv Neurol (2016) 0.78
Hemodynamic-morphological discriminant models for intracranial aneurysm rupture remain stable with increasing sample size. J Neurointerv Surg (2014) 0.78
Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review. Br J Anaesth (2016) 0.77
Clinical utility and cost-effectiveness of CT-angiography in the diagnosis of nontraumatic subarachnoid hemorrhage. Neuroradiology (2014) 0.77
Early endovascular treatment of aneurysmal subarachnoid hemorrhage complicated by neurogenic pulmonary edema and Takotsubo-like cardiomyopathy. Neuroradiol J (2014) 0.77
Time intervals from aneurysmal subarachnoid hemorrhage to treatment and factors contributing to delay. J Neurol (2013) 0.77
Fluid management of the neurological patient: a concise review. Crit Care (2016) 0.77
The critical care management of poor-grade subarachnoid haemorrhage. Crit Care (2016) 0.77
Factors and outcomes associated with ultra-early surgery for poor-grade aneurysmal subarachnoid haemorrhage: a multicentre retrospective analysis. BMJ Open (2015) 0.77
Prolonged Cerebral Circulation Time Is the Best Parameter for Predicting Vasospasm during Initial CT Perfusion in Subarachnoid Hemorrhagic Patients. PLoS One (2016) 0.77
A clinical characteristic analysis of pregnancy-associated intracranial haemorrhage in China. Sci Rep (2015) 0.77
Pathophysiologic differences in cerebral autoregulation after subarachnoid hemorrhage. Neurology (2016) 0.77
Hyperoxia results in increased aerobic metabolism following acute brain injury. J Cereb Blood Flow Metab (2016) 0.77
Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome. Neuroradiol J (2016) 0.76
Higher brain extracellular potassium is associated with brain metabolic distress and poor outcome after aneurysmal subarachnoid hemorrhage. Crit Care (2014) 0.76
Progesterone attenuates experimental subarachnoid hemorrhage-induced vasospasm by upregulation of endothelial nitric oxide synthase via Akt signaling pathway. Biomed Res Int (2014) 0.76
Downregulating hypoxia-inducible factor-1α expression with perfluorooctyl-bromide nanoparticles reduces early brain injury following experimental subarachnoid hemorrhage in rats. Am J Transl Res (2016) 0.76
20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients. J Cereb Blood Flow Metab (2015) 0.76
A Multicenter prospective study of poor-grade aneurysmal subarachnoid hemorrhage (AMPAS): observational registry study. BMC Neurol (2014) 0.76
A possible new focus for stroke treatment - migrating stem cells. Expert Opin Biol Ther (2015) 0.76
Aquaporin-4 and Cerebrovascular Diseases. Int J Mol Sci (2016) 0.76
Risk-benefit analysis of lumbar puncture to evaluate for nontraumatic subarachnoid hemorrhage in adult ED patients. Am J Emerg Med (2015) 0.76
Detection of wall and neck calcification of unruptured intracranial aneurysms with flat-detector computed tomography. Interv Neuroradiol (2016) 0.75
Early endovascular treatment of subarachnoid hemorrhage. Interv Neurol (2013) 0.75
Leptin levels after subarachnoid haemorrhage are gender dependent. Springerplus (2016) 0.75
Prophylactic Antiepileptics and Seizure Incidence Following Subarachnoid Hemorrhage: A Propensity Score-Matched Analysis. Stroke (2016) 0.75
Take care when taking care of fever after aneurysmal subarachnoid hemorrhage. Crit Care (2013) 0.75
Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management. Neuroradiol J (2013) 0.75
Treatment of ruptured intracranial aneurysms yesterday and now. PLoS One (2017) 0.75
Management of aneurysmal subarachnoid haemorrhage with intracerebral hematoma: Is there an indication for coiling first? Study of 44 cases. Interv Neuroradiol (2015) 0.75
Clinical Development and Implementation of an Institutional Guideline for Prospective EEG Monitoring and Reporting of Delayed Cerebral Ischemia. J Clin Neurophysiol (2016) 0.75
Protocol Based Real-Time Continuous Electroencephalography for Detecting Vasospasm in Subarachnoid Hemorrhage. J Korean Neurosurg Soc (2016) 0.75
Prognosis Predicting Score for Endovascular Treatment of Aneurysmal Subarachnoid Hemorrhage: A Risk Modeling Study for Individual Elderly Patients. Medicine (Baltimore) (2016) 0.75
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol (2008) 7.50
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc (2010) 5.42
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA (2011) 4.46
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Subarachnoid hemorrhage without evident cause on initial angiography studies: diagnostic yield of subsequent angiography and other neuroimaging tests. J Neurosurg (2003) 3.43
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke (2007) 3.36
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med (2004) 3.24
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation (2010) 3.17
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08
Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke (2011) 3.04
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Continuous EEG in therapeutic hypothermia after cardiac arrest: prognostic and clinical value. Neurology (2013) 2.97
Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura. Arch Neurol (2010) 2.91
Cerebral perfusion CT: technique and clinical applications. Radiology (2004) 2.91
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2012) 2.78
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Spinal epidural abscess: clinical presentation, management, and outcome. Surg Neurol (2005) 2.70
Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis (2011) 2.70
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med (2005) 2.62
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale. Circulation (2013) 2.56
Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke (2009) 2.55
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 2.50
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol (2010) 2.41
Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery (2002) 2.37